Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

# Molecular interaction of fibrinogen with zeolite nanoparticles

## Abstract

Fibrinogen is one of the key proteins that participate in the protein corona composition of many types of nanoparticles (NPs), and its conformational changes are crucial for activation of immune systems. Recently, we demonstrated that the fibrinogen highly contributed in the protein corona composition at the surface of zeolite nanoparticles. Therefore, understanding the interaction of fibrinogen with zeolite nanoparticles in more details could shed light of their safe applications in medicine. Thus, we probed the molecular interactions between fibrinogen and zeolite nanoparticles using both experimental and simulation approaches. The results indicated that fibrinogen has a strong and thermodynamically favorable interaction with zeolite nanoparticles in a non-cooperative manner. Additionally, fibrinogen experienced a substantial conformational change in the presence of zeolite nanoparticles through a concentration-dependent manner. Simulation results showed that both E- and D-domain of fibrinogen are bound to the EMT zeolite NPs via strong electrostatic interactions, and undergo structural changes leading to exposing normally buried sequences. D-domain has more contribution in this interaction and the C-terminus of γ chain (γ377–394), located in D-domain, showed the highest level of exposure compared to other sequences/residues.

## Introduction

Nanoparticles (NPs) have potential application for disease diagnosis and therapy1,2,3,4,5. It is well-recognized that the NP surfaces are instantaneously covered by a layer of biomolecules (so-called protein corona), when they come into contact with physiological fluids such as blood plasma6,7,8,9. The competitive adsorption of proteins on the NP surface is dependent on the physicochemical properties of NPs, incubation condition (time and temperature), and plasma protein alterations (protein concentration/structure) mediated by diseases9,10,11,12,13,14,15,16,17. In fact, the formation of protein corona changes the surface properties of NPs and it provides a biological mask, which is being “seen” by the biological systems such as cells7,18,19,20,21. The type, concentration and configuration of the participated proteins in the corona layer can give useful information for predicting the biological fate of NPs including their pharmacokinetics and biodistribution10,14,22,23,24,25.

During last few years, many studies were devoted on achieving in-depth information on the structural integrity of proteins after participating in the corona structure. As expected, the preliminary results revealed that the degree of structural rearrangement in protein is dependent on the protein type and physicochemical properties of NPs14,26,27. As an example of the role of protein type, fibrinogen demonstrated higher structural changes compared to albumin when interacting with graphene oxide14 and silica NPs27. Regarding the NPs’ properties, hydrophobic surfaces induce more structural changes to both albumin and fibrinogen compared to hydrophilic surfaces27.

Moreover, the structural variations of proteins can change their physiological functions. For example, we demonstrated that transferrin experiences irreversible structural changes and loose the main functionality (i.e., transport of iron among cells) after adsorption to the surface of iron oxide NPs28. Along with the functional changes, the structural changes in some proteins may activate inflammatory responses. For instance, structural changes in fibrinogen (i.e., exposure of its C-terminus of γ chain (γ377–395)), after interaction with poly(acrylic acid)-coated gold NPs, can provoke the inflammation response and downstream unwanted cascade pathways24.

Recently, we demonstrated that fibrinogen has the most contribution, among other plasma proteins, in the corona structure of the zeolite NPs29,30. Therefore, it is required to evaluate the structural integrity of zeolite-bound fibrinogen. To date, the molecular interactions between zeolite NPs and fibrinogen are not completely understood. The aim of this work is to understand the interactions of zeolite nanoparticles with fibrinogen using a wide range of theoretical and experimental approaches for probing the binding kinetics, and thermodynamic parameters and structural changes.

## Results and Discussion

### Characterization of EMT zeolite nanoparticles

Highly crystalline hexagonal EMT type zeolite NPs were synthesized and stabilized in water suspensions31,32. The particle size and the morphology of NPs were determined by dynamic light scattering (DLS) and transmission electron microscopy (TEM) techniques. The EMT nanocrystals indicated unimodal particle size distribution (8–20 nm) and hexagonal morphology (Fig. 1a,b). The porosity of the EMT zeolite was also measured. The EMT nanocrystals showed a combination of Types I and IV adsorption isotherm curves, indicating the presence of both micro- and textural meso- porosities (Fig. 1c)33 The size of the micropores determined using the DFT was 0.73 nm, which is in agreement with the size of the hypocage (0.75 nm × 0.65 nm in diameter) and hypercage (0.73 nm × 0.73 nm in diameter) of the EMT-type zeolite. In addition, the size of the mesopores was 3.1 nm, which is due to the close packing of the nanoparticles resulting in textural (inter-particles) porosity. The EMT zeolite nanoparticles have a BET surface area of 720 m2 g−1, external surface area of 260 m2 g−1, and total pore volume of 1.32 cm3 g−1. The chemical composition of the EMT zeolite was analysed using XRF spectroscopy. The unit cell composition was Na88 (AlO2)88(SiO2)104, with the Si/Al ratio equal to 1.17, suggesting that the zeolite surface was highly negatively charged. Hence, the high Na content was detected to counter balance the negative charge originated from the (Al–O–Si) groups. The surface charge and the charge density of EMT NPs were also calculated (see Methods section). The result showed that the EMT zeolite NPs contained a surface charge of −4356 mC g−1 due to the high surface area and high alumina content in the framework. As a result, the high surface charge density (−6.05 mC m−2) was calculated (Table 1). The high surface charge and high charge density of EMT NPs are thus in line with their hydrophilic and polar nature.

### Interaction of fibrinogen with EMT zeolite nanoparticles

Fluorescence spectroscopy is widely used to study the interaction of NPs and proteins34. It is known that the intrinsic tryptophan (TRP) fluorescence has significant changes through protein unfolding, leading to the exposure of internal TRP that is typically hidden in the folded state35. We probed fibrinogen-folding variations during the interaction with zeolite NPs using the leverage of TRP via monitoring the protein folding changes. The fluorescence spectra of fibrinogen were measured in the presence of various concentrations of EMT NPs at different temperatures (25, 37, 40 and 42 °C) (Fig. 1d). The maximum fluorescence peak (λmax) of fibrinogens incubated with EMT NPs was observed at 342 nm, and the fluorescence intensity of fibrinogen gradually decreased as the zeolite NPs concentration increased. These results indicate that the EMT NPs, which act as a quencher, have strong interactions with the fibrinogen. In this case, one may speculate that zeolite-bounded fibrinogen may experience structural rearrangement leading to the change in microenvironment of internal TRP. Molecular interaction between protein and zeolite NPs assists to perceive the origins in addition to have safe zeolites with more predictable biological efficacy. Therefore, several parameters involved in the fibrinogen-zeolite interaction are probed as described in the following sections.

### Quenching behavior of EMT zeolite nanoparticles

It is well-recognized that NPs quench the proteins in a dynamic or static manner36. Depending on the incubation temperature, the fluorophore–quencher complex is formed before (static) and/or after (dynamic) fluorophore excitation37. The quenching behavior of NPs is strongly dependent on the temperature at which proteins are incubated with NPs. The molecular mechanism of quenching is proposed using the Stern-Volmer equation (SI, Eq. S1). The Stern-Volmer plots and the constants of fibrinogen quenching induced by different concentrations of EMT NPs at various temperatures are shown in Fig. 2a and Table 2, respectively. As can be seen, a decrease in both the Stern-Volmer quenching constants and the slope of the Stern–Volmer plot is observed at higher temperatures. This result indicates that fibrinogen is mainly quenched in a static manner. Previously, we showed that slight change in incubation temperature affects the protein decoration on the surface of NPs and consequent biological responses38. Depending on the incubation temperature, different types and quantities of plasma proteins were adsorbed on the NPs11. This means that plasma proteins interact with NPs to different extent. Change in protein corona decoration is partly related to the protein conformational changes occurred at high temperature12. Thus, it can be suggested that newly exposed epitopes/sequences, as a result of protein unfolding, determine how proteins interact with the EMT zeolite NPs.

### Binding sites of protein on EMT zeolite nanoparticles

Fibrinogen showed different orientations on the NPs surface, which is depending on the physicochemical properties of NPs (surface charge, size, surface curvature), the type of presorted proteins and the degree of NP surface coverage27,39,40. For example, fibrinogen tends to be adsorbed on small-sized gold (5.6–14 nm) and silica (15–60 nm) NPs via side-on configuration27,40. However, fibrinogen preferably attached to NPs surface through end-on configuration as the size of NPs increased40. The number of binding sites per protein was calculated using double–logarithm equation (Fig. 2b and SI: Eq. S2)41. The proteins that adopt a side-on configuration wrap the NP surface and therefore, engage more binding sites compared to the end-on state. As expected, fibrinogen, which is a hydrophilic protein, has more than one, binding sites on EMT zeolite NPs (Table 3). It is suggested that fibrinogen is mainly adsorbed on EMT NPs through side-on configuration. The influence of incubation temperature on fibrinogen-NPs interactions is presented in Fig. 2b. The number of binding sites per protein decreased as the incubation temperature increased from 25 to 42 °C. Thus, the temperature-induced conformational changes affect the orientation of proteins on the NPs. The proteins adopted in the side-on/end-on configuration may reorient to end-on/side-on state after structural rearrangement. Depending on the protein unfolding extent and protein orientation model, the protein-NPs interaction may form different binding strengths. Therefore, various binding energies of the interaction at different temperatures can be explained by temperature-induced conformational changes.

### Cooperativity assay of fibrinogen and EMT zeolite nanoparticles

Binding kinetics and cooperativity in fibrinogen-zeolite NPs interaction were assessed using Hill equation (SI: Eq. S3). Hill coefficient determines whether different binding sites involved through protein-NP interaction are self-governed or cooperative. The calculated Hill coefficient in physiological like condition is near to 1 implying that single or multiple self-governing binding sites mediate the fibrinogen-zeolite interaction (Fig. 2c) (SI: Figs S1–S3)42. For non-cooperative protein binding, where Hill coefficient is near to 1, the affinity of proteins to NP surface is independent of the pre-sorbed proteins. Fibrinogen has multiple domains that potentially interact with different surfaces. For example, domains D and E illustrated different affinities to the same surface43. They also attached to zeolite NPs independently. It can be suggested that the adsorption and subsequent unfolding of each domain do not affect neighboring domain adsorption/structure.

The particle size plays crucial role in determining the cooperativity in NPs-protein interaction40. Considerable contradictories exist in the literatures regarding the effect of NPs size on the cooperativity in NPs-fibrinogen interaction. For example, Deng et al.39, showed positive cooperativity occurred when fibrinogen interacted with the gold NPs larger than 7 nm. In contrast, Lacerda et al.44, demonstrated that fibrinogen preferably bound to gold NPs larger than 5 nm in a negative cooperative manner.

### Analysis of thermodynamic parameters involved in the EMT zeolite nanoparticles and fibrinogen interactions

The thermodynamic parameters involved in fibrinogen–EMT NPs interaction were measured using fluorescent spectroscopy. Thermodynamic parameters such as enthalpy (ΔH), Gibbs free energy (ΔG) (Table 4), and entropy (ΔS) changes were indirectly calculated using the equations S4 and S5 (SI) to determine the governing forces on the fibrinogen−EMT NPs interaction. The negative values for ΔG indicate that the interaction occurs spontaneously. The negative values of ΔH (−2699.05 J mol−1 K−1) and ΔS (−787.16 J mol−1 K−1) imply that van der Waals (vdW) forces and hydrogen bonds are also involved in EMT−fibrinogen interaction45. Based on the exothermic reaction and the thermodynamic parameters obtained from van’t Hoff equation and corresponded plots of fibrinogen−EMT interactions, it is suggested that fibrinogen has a high affinity towards EMT NPs (Fig. 2d).

### Secondary structure of bound fibrinogen on EMT zeolite nanoparticles

The secondary structure of fibrinogen was studied in the presence of various concentrations of EMT NPs using far-ultraviolet circular dichroism (CD) analytical approach. The CD spectra were recorded in the wavelength range 190−260 nm (SI: Figs S4S7 and Tables S1S10). Two negative peaks appeared at 208 nm and 222 nm; these peaks are characteristic of typical fibrinogen structure having α-helix (Fig. 2e). The reduced ellipticity at 208 nm and 222 nm indicates that the α-helix content of fibrinogen treated with NPs decreased significantly. This means that the secondary structure of fibrinogen significantly changes in the presence of EMT zeolite NPs (Fig. 2f). In addition, the degree of protein conformational changes gradually increased with increasing the NP concentration.

### Mechanistic understanding of fibrinogen-EMT zeolite interaction via molecular dynamics simulations

The detailed mechanism of interactions between EMT zeolite NPs and fibrinogen D-/E-domains was studied using molecular dynamics (MD) simulations (Figs 3a–h and 4a–f). The MD simulation analyses showed that binding of fibrinogen to EMT zeolite can change the structure of fibrinogen. To investigate the pro-inflammatory potential of EMT zeolite in atomistic views, the simulation of fibrinogen D-domain was performed in the presence and absence (as a control) of zeolite NPs (Figs 3a–h and 5a–f). The root mean square deviation (RMSD) analysis showed that the D-domain has more stability in interaction with zeolite NPs compared to the D-domain alone. The root mean square fluctuations (RMSF) also decreased for D-domain interacted with the EMT zeolite NPs indicating the higher stability of the D-domain interacting with the EMT zeolite NPs (Fig. 6a,c,d). The most striking observation is that γ377–394 flexibility increased through interaction of D-domain with EMT zeolite NPs. The data obtained from this analysis revealed that at first, turns of β-chain (in D-domain) have critical role in binding of the D-domain to the EMT zeolite NPs. The non-polar (Ala335) and polar (Asn333) residues located in β-chain mediate the adsorption of protein onto the EMT zeolite surface (Fig. 3a). After binding of D-domain to EMT zeolite NPs, hydrophobic residue (Leu172) changes the configuration of D-domain possibly through hydrophobic interactions (according to the observed simulation outcomes; please see Fig. 3b for details) with other residues and EMT zeolite NPs. During simulations, other residues in γ-chain interact with EMT zeolite. Moreover, the interactions between turns of β and γ chains affect the orientation and exposure of residues. For example, the interaction of Ser231 located in β-chain with LYS170 located in γ-chain changes the orientation of D-domain on the surface of the EMT zeolite NPs (Fig. 3c). The Ser231-Lys170 interaction mediates binding of Leu172 to EMT zeolite surface via hydrophobic-hydrophobic interactions (Fig. 3d). Then, Asn390 forms hydrogen bonds with the surface and trigger the formation of hydrogen bonds between D-domain and EMT zeolite (Figs 3e and 7a). In addition, the positively charged Lys159 interacted with the negatively charged oxygen atoms in EMT zeolite through electrostatic interaction (Figs 3e,f,g and 7c). The γ-chain residues (viz. Lys159, Lys170, Lys173, Lys196, Asp199, Asp203, Lys206, Glu213, His217, Glu225, Glu231, Lys232, His234, Glu249, Glu251, Asp252, Asp26, Lys266, Glu270, Lys273, Asp285, Asp291, Asp294, Asp297, Asp298, Asp301, Lys302, His307, Asp320, Lys321, Glu323, Glu328, Asp330, Lys338, His340, His343, Lys356, Lys373, Lys380, Lys381) are involved in electrostatic interactions with EMT zeolite NPs (Fig. 7c).

In addition to electrostatic interactions, stable hydrogen bonds are formed between polar residues (Asn158) and the EMT zeolite NPs (Fig. 3h). The consequence of all these events is exposing the C-terminus of γ-chain, γ377–394 (Tyr377-Ser378-Met379-Lys380-Lys381-Thr382-Thr383-Met384-LYS385-Ile386-Ile387-Pro388-Phe389-Asn390-Arg391-Leu392-Thr393 -Ile394) (Fig. 3). The solvent accessible surface area (SASA) was calculated to study the exposing of the C-terminus of γ-chain during interaction with zeolite NPs (Fig. 8a–d). The SASA was calculated for alone D-domain protein and D-domain interacted with the EMT zeolite NPs. The differences of SASA for two setups (∆SASA = SASAD-domain − SASAD-domain- EMT zeolite) with error bars of 0.01 were presented to identify the important residues exposed when D-domain of fibrinogen interact with the EMT zeolite NPs (Fig. 8c,d). This analysis strongly confirms the contact of γ377–394 with the EMT zeolite NPs. As depicted in Fig. 8c,d, the γ377–394 showed the highest level of exposure (3σ) in comparison to other sequences/residues by considering the error bar (0.01). The exposure of residues from γ, β and α-chains are ranked in the following orders respectively: (γ) Ile394 > Phe295 > Lys173 > Asp104 > Asp301 > Trp315 > Lys159 > Leu235 > Ser237; (β) Trp385 > Phe458 > Lys396 > Trp444 > Gln393; (α) Leu193 > Arg197 > Leu122 > Gln200 (Fig. 8a–d).

To get deeper understanding on the interaction of fibrinogen with the EMT zeolite NPs, we also simulated E-domain of this protein (Figs 4a–f and 5g–l). The non-polar residue (Leu66) triggers the movement of E-domain towards the surface of the EMT zeolite NPs (Fig. 4a,b). In addition, the hydrophobic residues including Cys65, Phe74 and Ala68 are involved in this interaction via hydrophobic forces. It seems at early stages, the hydrophobic residues facilitate the interaction between E-domain and the EMT zeolite NPs. Indeed, binding of E-domain to the EMT zeolite is initiated and stabilized via hydrophobic and electrostatic forces, respectively (Fig. 7c). At initial steps, hydrophobic residues keep the E-domain near to zeolite and then polar (Gln88, Gln89 and Arg91) and charged (Lys70α-chain, Lys78α-chain, Lys81β-chain Glu84β-chain and Glu99β-chain) residues mediate the attachment of E-domain to the surface of the EMT zeolite (Fig. 4c,d). Arg14 and Arg91 also mediate the binding of E-domain to the EMT zeolite through interaction with NP surface, respectively (Fig. 4e). Moreover, Gln81, Glu84, Gln88, Asn95 and Glu99 residues interact with zeolite via electrostatic interactions and form hydrogen bonds (Fig. 4e,f). By calculating the vdW and electrostatic interactions, and also the hydrogen bonds between E-domain and zeolite, we found out the key role of negative charged residues (such as Glu84) in E-domain-zeolite interactions (Fig. 7). For D-domain, the positive charged residues, such as Lys159, keep fibrinogen in contact to zeolite for a long time, while for E-domain the negative charged residues, such as Glu84β-chain, play this role (Figs 3 and 4).

The RMSD and RMSF analyses showed that E-domain has more stable interaction with zeolite NPs compared to E-domain alone (Fig. 6b,e,f). Calculated electrostatic and vdW interactions between D/E-domain and EMT zeolite indicated that D-domain has more contribution in the interactions of fibrinogen with the EMT zeolite NPs than E-domain thanks to its high affinity to EMT zeolite exposed to the γ377–394 (Fig. 7c). Moreover, larger number of hydrogen bonds during the interaction of D-domain with the EMT zeolite NPs are formed compared to E-domain (Fig. 7a,b).

The SASA calculation was performed for E-domain in the presence and absence of the EMT zeolite in order to identify the residues exposed through interaction of E-domain with the EMT zeolite (Fig. 8e–h). In the case of E-domain, the exposure of residues from α, β and γ chains is ranked in following orders respectively: (α) Lys29 > Ser31 > Ile119 > Lys36 > Arg104 > Glu92 > Met91 > Lys44; (β) Val132 > Leu146 > Tyr117 > Glu90 > His149 > Trp125; (γ) Tyr32 > Ile100 > Ser74 > Pro70 > Tyr68 > Ala26 > Ile61.

## Discussion

The structural integrity of NPs bound proteins determines the in vivo fate of NP and biological responses. Understanding the NPs−protein interaction is crucial for predicting the therapeutic and/or toxic impacts of NPs in vivo. The structural changes in proteins, after association within the corona layer, can affect the cellular uptake mechanism of nanoparticles. For example, bovine serum albumin (BSA) proteins adsorbed on the surface of cationic polystyrene NPs experienced structural changes, while the bounds to anionic polystyrene remained intact46. These variations in the protein structure at the corona layer led to different interactions of the NPs with the cell receptors, i.e. the BSA-coated cationic and anionic NPs bounded to scavenger and native albumin receptors, respectively. In a similar study, Minchin group47 demonstrated that the silica NPs have capability to change the albumin’s structure, leading to exposure of a typical hidden epitope, which is exclusively recognized by macrophages expressing class A receptor. Prapainop et al.48, demonstrated that apolipoprotein conformation was changed after binding to quantum dots and it substantially increased their uptakes by macrophages. Thus, the challenges associated with the structural integrity of corona proteins raised serious concerns about the in vivo fate/behavior of NPs. Zeolite NPs have promising potential medical applications including drug delivery, imaging, and microbial infection and neurodegenerative diseases therapy49,50,51,52. Probing the structure of adsorbed proteins on the surface of zeolite NPs is of great interest as it helps scientists in the field to maximize the therapeutic efficacy of these particles while maintaining the toxic effects at a minimal level. This study revealed that the interaction between zeolite NPs and fibrinogen was strong, thermodynamically favorable and occurred in a non-cooperative manner. The EMT zeolite NPs considerably changed the secondary structure of fibrinogen.

MD simulations provide unique opportunity to understand the detailed mechanism of fibrinogen-EMT zeolite interactions. The data obtained from simulation studies had shown that fibrinogen binds to EMT zeolite through strong electrostatic and hydrophobic interactions. In fact, D- and E-domains, which have high affinity to EMT zeolite, are involved in this interaction. The binding affinity of D- and E-domains were calculated using linear interaction energy (LIE) method53. This analysis indicated that the affinity of D-domain to the surface of zeolite is 5 kBT higher than for the E-domain. This result implies that the D-domain has key role in binding of fibrinogen to EMT zeolite. D-domain plays the dominant role in binding of fibrinogen to EMT zeolite and undergoes highest level of structural changes leading to exposing the C-terminus of γ chain (γ377–394). Such exposure of the C-terminus of γ chain (γ377–394) is known to interact with integrin receptors which may in turn trigger inflammation response24. However, such inflammatory effects should be monitored in the actual in vivo conditions as the zeolite nanoparticles will interact with the entire plasma proteins and not the fibrinogen alone.

## Materials and Methods

### Synthesis and characterization of EMT zeolite NPs

The EMT zeolite NPs were synthesized as described previously31. Aluminate solution was prepared by mixing 9.074 g of sodium aluminate (Strem Chemicals), 1.61 g of sodium hydroxide (Prolabo, 97%) and 100 g of double distilled water. The mixture was stirred for 10 min before another 44.00 g of sodium hydroxide was added to the solution. The mixture was continuously stirred until a clear aluminate solution was obtained. The silicate solution was prepared by dissolving 57.692 g of sodium silicate (Prolabo, 27% SiO2, 8% Na2O) and 20.00 g of sodium hydroxide in 80.00 g of double distilled water. The preparation of both solutions are exothermic and hence both solutions should be cooled down in an ice bath (4 °C) prior mixing. The aluminate solution was then slowly poured into the silicate solution under magnetic stirring (800 rpm); a white colloidal suspension with a molar composition of 1Al2O3:5.15SiO2:18.45Na2O:240H2O was obtained. The resulting suspension was stirred for additional 5 min before it was crystallized at 30 °C for 36 h under static condition. The resulting EMT zeolite nanocrystals were then centrifuged (20000 rpm for 1 h) and purified with distilled water until the pH of the suspension reached 7.

The XRD patterns of zeolite NPs were obtained using a PANalytical X’Pert PRO XRD diffractometer (step size 0.01°, 1.5 seconds per step, Cu-Kα radiation). The morphology and crystallite size of zeolite samples were inspected by a transmission electron microscope (TEM) (JEOL Model 2010 FEG system, 200 kV). The average size of zeolite NPs was determined by randomly counting 50 particles through TEM observations obtained in different regions. The hydrodynamic size and zeta potential, ξ, of colloidal solution of zeolite NPs (1 wt%, pH = 7, 25 °C) were measured by a Malvern Zetasizer Nano Series equipment. The surface charge density, σ, was calculated using the Grahame equation (Eq. 1):

$${\rm{\sigma }}=\sqrt{8{{\rm{c}}}_{0}{{\rm{\varepsilon }}{\rm{\varepsilon }}}_{0}{{\rm{k}}}_{{\rm{B}}}{{\rm{N}}}_{{\rm{A}}}{\rm{T}}}\times \,\sinh (\frac{{{\rm{e}}{\rm{\Psi }}}_{0}}{2{{\rm{k}}}_{{\rm{B}}}{\rm{T}}})$$
(1)

where c0 is the concentration of zeolite (0.1%) in suspension in unit m3, εε0 is the dielectric permittivity of EMT zeolite (1.3547 × 10−11 AsV−1 m−1), kB is the Boltzmann constant (1.381 × 10−23 J K−1), Ψ0 is the surface potential or zeta potential of the zeolite suspension (−45.7 mV), e is the electronic charge (1.602 × 10−19 C), and T is the absolute temperature (298 K).

The surface charge of the EMT NPs, Q, was calculated by Eq. 2:

$${\rm{Q}}=\frac{{\rm{\sigma }}\times {{\rm{S}}}_{{\rm{BET}}}}{{\rm{Si}}/{\rm{Al}}\,{\rm{ratio}}}$$
(2)

where SBET is the specific surface area (m2 g−1) and Si/Al ratio is the silicon to aluminum ratio of the zeolite NPs.

The elemental composition of zeolite NPs was characterized by using a Phillips X’Unique X-ray Fluorescence (XRF) spectrometer. The porosity of zeolite NPs was analysed by a Micromeritics ASAP 2010 nitrogen adsorption analyzer. Prior to analysis, the powder was dehydrated at 250 °C under vacuum overnight. The specific surface area was calculated using the BET equation whiles the external surface area and micropore volume were computed using the t-plot technique. The pore sizes were calculated using the Density Functional Theory (DFT) model.

### Fluorescence spectroscopy

Fluorescence quenching of fibrinogen was measured in the presence of zeolite NPs with different concentrations using a Hitachi MPF-4 spectrofluorometer equipped with a thermostatically controlled cuvette compartment. The fluorescent property of fibrinogen is related to its aromatic amino acids such as tryptophan (Excitation: 280 nm; Emission: 360 nm). This analysis was performed at different temperatures (25, 37, 40 and 42 °C) to determine the effect of temperature on quenching process. The protein and NPs concentrations were 0.588 µM and 17–102 µM, respectively.

The fluorescence quenching was quantified by the following Eq. 3:

$${\rm{Q}}=({{\rm{F}}}_{0}-{\rm{F}})/{{\rm{F}}}_{0}$$
(3)

where F0 and F are fluorescence intensities in the absence and presence of NPs, respectively44. The association constant K is the reciprocal of the “dissociation constant”, kD. The Stern-Volmer equation (SI: Eq. S1) is used to assess the efficiency and mechanism of fluorescence quenching. By assuming that the NPs–protein binding occurs at the equilibrium condition, the quenching data was fitted for Q to determine an association constant (Kα) to describe the NP–protein interaction (SI: Eq. S2). As fibrinogen potentially binds to the surface of zeolite NPs with different domains/binding sites, which displays the cooperativity in the binding equilibrium as expected. The binding kinetics and cooperativity in fibrinogen–zeolite interaction were determined using Hill equation (SI, Eq. S3).

### Circular dichroism (CD) spectroscopy

Fibrinogen (1 mg mL−1) was incubated with zeolite suspensions with different concentrations (concentration range from 4.25 to 119 µM) for 1 h at 37 °C. The CD spectra of resulting suspensions were recorded at the wavelengths between 190 and 260 nm with an average of 20 scans using a Aviv model 215 spectropolarimeter (Lakewood, NJ, USA). All CD measurements were performed at room temperature (25 °C), in a 1 mm path cuvette. The ellipticity was represented in milli degrees.

### Molecular dynamic simulation

All atomistic MD simulations were carried out using GROMACS 4.6.0 MD software and OPLSAA force field54. The OPLSAA force field was used for the EMT zeolite NPs, D-domain and E-domain with the TIP3P water model. The crystal structure of human fibrinogen was taken from Protein Data Bank under PDB entry 3GHG. The AutoDock Vina software was also used to perform the docking simulations55. These four setups (D-domain, D-domain-EMT zeolite, E-domain and E-domain-EMT zeolite) were minimized using steepest descent algorithm to remove any unfavorable interactions and then equilibrated in the NPT ensemble before 10-ns MD simulations in a neutralized aqueous solution (with the appropriate number of Na and Cl ions) in order to achieve biological conditions. The temperature and pressure were maintained in biological conditions (310 K, 1 bar) using V-rescale thermostat with a coupling time constant of 0.5 ps, and the Berendsen barostat with 0.5 ps coupling time constant after minimization steps. Time steps for all systems were 1 fs and neighbor lists were updated every 20 steps with a list cut off of 1.2 nm. In order to accurate coverage of long range interactions the particle mesh Ewald summation (PME) method with a direct space cut-off of 1.2 nm and a 4 cubic interpolation order was used56. In reciprocal space, 0.12 nm Fourier spacing (grid spacing for a fast Fourier transform) was used for controlling the wave vectors highest magnitude. For constraining bonds, the linear constraint solver (LINCS) algorithm was applied57. In order to integrate the motion equations, the leapfrog algorithm was used and simulations of all 4 setups (D-domain, D-domain-EMT zeolite, E-domain and E-domain-EMT zeolite) were replicated four times (all results were averaged). Visualizations of simulated systems including D-domain, D-domain-EMT zeolite, E-domain and E-domain-EMT zeolite were done using a VMD 1.9.358.

## References

1. 1.

Hajipour, M. J. et al. Advances in alzheimer’s diagnosis and therapy: The implications of nanotechnology. Trends in biotechnology 35, 937–953 (2017).

2. 2.

Hajipour, M. J. et al. Antibacterial properties of nanoparticles. Trends in biotechnology 30, 499–511 (2012).

3. 3.

Krol, S. et al. Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. Chemical reviews 113, 1877–1903 (2012).

4. 4.

Ghaemi, B. et al. Harnessing the cancer radiation therapy by lanthanide-doped zinc oxide based theranostic nanoparticles. ACS applied materials & interfaces 8, 3123–3134 (2016).

5. 5.

Najafi-taher, R., Ghaemi, B., Kharazi, S., Rasoulikoohi, S. & Amani, A. Promising Antibacterial Effects of Silver Nanoparticle-Loaded Tea Tree Oil Nanoemulsion: a Synergistic Combination Against Resistance Threat. AAPS PharmSciTech, 1–8 (2017).

6. 6.

Lynch, I. & Dawson, K. A. Protein-nanoparticle interactions. Nano today 3, 40–47 (2008).

7. 7.

Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A. & McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Advanced drug delivery reviews 61, 428–437 (2009).

8. 8.

Cedervall, T. et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proceedings of the National Academy of Sciences 104, 2050–2055 (2007).

9. 9.

Mahmoudi, M. et al. Protein− nanoparticle interactions: opportunities and challenges. Chemical reviews 111, 5610–5637 (2011).

10. 10.

Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nature nanotechnology 8, 772–781 (2013).

11. 11.

Mahmoudi, M. et al. Temperature: the “ignored” factor at the nanobio interface. ACS nano 7, 6555–6562 (2013).

12. 12.

Mahmoudi, M. et al. Variation of protein corona composition of gold nanoparticles following plasmonic heating. Nano letters 14, 6–12 (2013).

13. 13.

Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F. & Mahmoudi, M. Personalized protein coronas: a “key” factor at the nanobiointerface. Biomaterials Science 2, 1210–1221 (2014).

14. 14.

Hajipour, M. J. et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale 7, 8978–8994 (2015).

15. 15.

Tavakol, M. et al. Disease-related metabolites affect protein-nanoparticle interactions. Nanoscale (2018).

16. 16.

Hajipour, M. J. et al. Sensing of Alzheimer’s Disease and Multiple Sclerosis Using Nano-Bio Interfaces. Journal of Alzheimer’s Disease 59, 1187–1202 (2017).

17. 17.

Lotfabadi, A. et al. Biomolecular Corona Dictates Aβ Fibrillation Process. ACS chemical neuroscience (2018).

18. 18.

Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I. & Dawson, K. A. What the cell “sees” in bionanoscience. Journal of the American Chemical Society 132, 5761–5768 (2010).

19. 19.

Walkey, C. D. & Chan, W. C. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chemical Society Reviews 41, 2780–2799 (2012).

20. 20.

Röcker, C., Pötzl, M., Zhang, F., Parak, W. J. & Nienhaus, G. U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nature nanotechnology 4, 577–580 (2009).

21. 21.

Bakhtiary, Z. et al. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges. Nanomedicine: Nanotechnology, Biology and Medicine 12, 287–307 (2016).

22. 22.

Hajipour, M. J., Akhavan, O., Meidanchi, A., Laurent, S. & Mahmoudi, M. Hyperthermia-induced protein corona improves the therapeutic effects of zinc ferrite spinel-graphene sheets against cancer. RSC Advances 4, 62557–62565 (2014).

23. 23.

Shanehsazzadeh, S., Lahooti, A., Hajipour, M. J., Ghavami, M. & Azhdarzadeh, M. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles. Colloids and Surfaces B: Biointerfaces 136, 1107–1112 (2015).

24. 24.

Deng, Z. J., Liang, M., Monteiro, M., Toth, I. & Minchin, R. F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature nanotechnology 6, 39–44 (2011).

25. 25.

Raoufi, M. et al. Probing fibronectin conformation on a protein corona layer around nanoparticles. Nanoscale (2018).

26. 26.

Roach, P., Farrar, D. & Perry, C. C. Interpretation of protein adsorption: surface-induced conformational changes. Journal of the American Chemical Society 127, 8168–8173 (2005).

27. 27.

Roach, P., Farrar, D. & Perry, C. C. Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. Journal of the American Chemical Society 128, 3939–3945 (2006).

28. 28.

Mahmoudi, M. et al. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 3, 1127–1138 (2011).

29. 29.

Rahimi, M. et al. Zeolite Nanoparticles for Selective Sorption of Plasma Proteins. Scientific reports 5 (2015).

30. 30.

Laurent, S. et al. Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions. Toxicology Research 2, 270–279 (2013).

31. 31.

Ng, E.-P., Chateigner, D., Bein, T., Valtchev, V. & Mintova, S. Capturing ultrasmall EMT zeolite from template-free systems. Science 335, 70–73 (2012).

32. 32.

Ng, E.-P., Sekhon, S. S. & Mintova, S. Discrete MnAlPO-5 nanocrystals synthesized by an ionothermal approach. Chemical Communications, 1661–1663 (2009).

33. 33.

Ng, E.-P. et al. EMT-type zeolite nanocrystals synthesized from rice husk. Microporous and Mesoporous Materials 204, 204–209 (2015).

34. 34.

Gheshlaghi, Z. N., Riazi, G. H., Ahmadian, S., Ghafari, M. & Mahinpour, R. Toxicity and interaction of titanium dioxide nanoparticles with microtubule protein. Acta biochimica et biophysica Sinica 40, 777–782 (2008).

35. 35.

Lakowicz, J. R. Principles of fluorescence spectroscopy. (Springer Science & Business Media, 2013).

36. 36.

Lakowicz, J. R. In Principles of fluorescence spectroscopy. 291–319 (Springer, 1999).

37. 37.

Zhang, G., Zhao, N. & Wang, L. Fluorescence spectrometric studies on the binding of puerarin to human serum albumin using warfarin, ibuprofen and digitoxin as site markers with the aid of chemometrics. Journal of Luminescence 131, 2716–2724 (2011).

38. 38.

Mahmoudi, M., Shokrgozar, M. A. & Behzadi, S. Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles. Nanoscale 5, 3240–3244 (2013).

39. 39.

Deng, Z. J., Liang, M., Toth, I., Monteiro, M. J. & Minchin, R. F. Molecular interaction of poly (acrylic acid) gold nanoparticles with human fibrinogen. ACS nano 6, 8962–8969 (2012).

40. 40.

Deng, J., Sun, M., Zhu, J. & Gao, C. Molecular interactions of different size AuNP–COOH nanoparticles with human fibrinogen. Nanoscale 5, 8130–8137 (2013).

41. 41.

Sklar, L. A., Hudson, B. S. & Simoni, R. D. Conjugated polyene fatty acids as fluorescent probes: binding to bovine serum albumin. Biochemistry 16, 5100–5108 (1977).

42. 42.

Gao, J., Lai, Y., Wu, C. & Zhao, Y. Exploring and exploiting the synergy of non-covalent interactions on the surface of gold nanoparticles for fluorescent turn-on sensing of bacterial lipopolysaccharide. Nanoscale 5, 8242–8248 (2013).

43. 43.

Hall, C. E. & Slayter, H. S. The fibrinogen molecule: its size, shape, and mode of polymerization. The Journal of Cell Biology 5, 11–27 (1959).

44. 44.

Lacerda, S. H. D. P. et al. Interaction of gold nanoparticles with common human blood proteins. ACS nano 4, 365–379 (2009).

45. 45.

Mu, Y., Lin, J. & Liu, R. Interaction of sodium benzoate with trypsin by spectroscopic techniques. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 83, 130–135 (2011).

46. 46.

Fleischer, C. C. & Payne, C. K. Nanoparticle surface charge mediates the cellular receptors used by protein–nanoparticle complexes. The Journal of Physical Chemistry B 116, 8901–8907 (2012).

47. 47.

Mortimer, G. M. et al. Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. ACS nano 8, 3357–3366 (2014).

48. 48.

Prapainop, K., Witter, D. P. & Wentworth, P. Jr. A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. Journal of the American Chemical Society 134, 4100–4103 (2012).

49. 49.

Young, S. W. et al. Gadolinium zeolite as an oral contrast agent for magnetic resonance imaging. Journal of Magnetic Resonance Imaging 5, 499–508 (1995).

50. 50.

Flores-López, N. et al. Synthesis and properties of crystalline silver nanoparticles supported in natural zeolite chabazite. Journal of Molecular Structure 1028, 110–115 (2012).

51. 51.

Tavolaro, A., Riccio, I. I. & Tavolaro, P. Hydrothermal synthesis of zeolite composite membranes and crystals as potential vectors for drug-delivering biomaterials. Microporous and Mesoporous Materials 167, 62–70 (2013).

52. 52.

Derakhshankhah, H. et al. Zeolite Nanoparticles Inhibit Aβ–Fibrinogen Interaction and Formation of a Consequent Abnormal Structural Clot. ACS Applied Materials & Interfaces 8, 30768–30779 (2016).

53. 53.

Åqvist, J., Luzhkov, V. B. & Brandsdal, B. O. Ligand binding affinities from MD simulations. Accounts of chemical research 35, 358–365 (2002).

54. 54.

Hess, B., Kutzner, C., Van Der Spoel, D. & Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of chemical theory and computation 4, 435–447 (2008).

55. 55.

Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry 31, 455–461 (2010).

56. 56.

Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N log (N) method for Ewald sums in large systems. The Journal of chemical physics 98, 10089–10092 (1993).

57. 57.

Hess, B., Bekker, H., Berendsen, H. J. & Fraaije, J. G. LINCS: a linear constraint solver for molecular simulations. Journal of computational chemistry 18, 1463–1472 (1997).

58. 58.

Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. Journal of molecular graphics 14, 33–38 (1996).

## Acknowledgements

This work was supported by grants from the Kermanshah University of medical sciences and Bushehr University of medical sciences.

## Author information

Authors

### Contributions

M.J.H. and M.M. proposed the original idea. H.D., F.T., S.J., A.R.L., S.S., A.F., A.G., E.B., M.E., A.A.S., S.M.K.S., B.G., F.O., I.N., M.R., R.D. and K.S. performed the experiments. A.H. and M.R.E. conducted the simulation analyses. E.P.N., H.A. and S.M. synthesized and characterized EMT zeolite. M.J.H. designed the experimental and simulation analyses and wrote the manuscript. M.R.E., S.M. and M.M. assisted in interpreting analysis of the data, discussions and writing the manuscript.

## Ethics declarations

### Competing Interests

The authors declare no competing interests.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## Rights and permissions

Reprints and Permissions

Derakhshankhah, H., Hosseini, A., Taghavi, F. et al. Molecular interaction of fibrinogen with zeolite nanoparticles. Sci Rep 9, 1558 (2019). https://doi.org/10.1038/s41598-018-37621-4

• Accepted:

• Published:

• ### Diatomite incorporation in zeolite Fu-1

• Paloma Vinaches
• , Severino H. da Silva Filho
• , Iane M.S. Souza
•  & Sibele B.C. Pergher

Materials Letters (2021)

• ### Anti‐Platelet Effect Induced by Iron Oxide Nanoparticles: Correlation with Conformational Change in Fibrinogen

• Regina Komal Kottana
• , Lionel Maurizi
• , Brian Schnoor
• , Kenise Morris
• , Jessica Ann Webb
• , Michael Anthony Massiah
•  & Anne‐Laure Papa

Small (2021)

• ### Nanoporous iron oxide nanoparticle: hydrothermal fabrication, human serum albumin interaction and potential antibacterial effects

• Masoumeh Mehrabi
• , Behnam Rasti
• , Mojtaba Falahati
• , Amir Mirzaie
•  & Anwarul Hasan

Journal of Biomolecular Structure and Dynamics (2021)

• ### Interdependency of influential parameters in therapeutic nanomedicine

• Seyed Mehdi Kamali Shahri
• , Shahriar Sharifi
•  & Morteza Mahmoudi

Expert Opinion on Drug Delivery (2021)

• ### Construction and Application of EGCG-Loaded Lysozyme/Pectin Nanoparticles for Enhancing the Resistance of Nematodes to Heat and Oxidation Stresses

• Yu Zhang
• , Liufeng Lin
• , Hao Cui
• , Bin Li
•  & Jing Tian

Foods (2021)